CCL4 and metabolic syndrome: In addition, mice receiving the CCL4 antibody showed lower serum insulin levels (Figure 4A), higher insulin-positive areas and more intact with large pancreatic volume and closely arranged pancreatic β-cells morphology (Figures 4B, C) than the IgG-treated metabolic syndrome mice.